CIML is proud to announce that Dr. Anaïs Rogier, a young researcher trained at our institute in Sophie Ugolini's team as a doctoral student, has received the prestigious Aix-Marseille University Thesis Award for her remarkable work defended in 2023.
Each year, Aix-Marseille University grants this prestigious award to recognize the…
L'Inserm annonce le financement du projet ANTIBAX à hauteur de 2,3 millions d'euros dans le cadre du programme Impact Santé de France 2030. Ce projet innovant, auquel contribue Pierre Milpied du Centre d'Immunologie de Marseille-Luminy (CIML), vise à développer des anticorps monoclonaux ciblant les bactéries impliquées dans les cancers des…
CIML is proud to announce the exceptional recognition of two outstanding French immunologists, Bernard Malissen and Eric Vivier, who have been honored as Highly Cited Researchers. This prestigious distinction celebrates their extraordinary scientific contributions and remarkable impact in the field of immunology.The Highly…
Researchers from the Centre d'Immunologie de Marseille Luminy (CIML) have made a significant breakthrough in understanding the development of regulatory T cells (Tregs), which are essential players in controlling our immune system. This discovery could have important implications for the treatment of various autoimmune and inflammatory diseases…
Researchers from the Centre d'Immunologie de Marseille-Luminy (CIML), led by Dr. Achille Broggi, have uncovered a key mechanism that slows tissue repair in the intestines during inflammation. This discovery, published in the prestigious journal Cell, could revolutionize the treatment of chronic inflammatory bowel diseases (IBD…
As part of the Science Festival, the Centre d'Immunologie de Marseille-Luminy (CIML) successfully launched its educational campaign "Dive into the Heart of Our Immunity," offering high school students from Marseille a fascinating immersion into the world of our natural defenses.
This innovative educational initiative allowed students from…
The CIML (Inserm/CNRS/AMU) is proud to announce that Dr. Sandrine Roulland, Inserm Research Director and team leader at CIML, has been selected as a recipient of the prestigious Idea Award from the Institute for Follicular Lymphoma Innovation (IFLI).
This distinction, which is part of the Moonshot program launched in June 2023, recognizes…
The CIML is proud to announce that Temper Bio, co-founded by Sophie Ugolini, Inserm Research Director and team leader at CIML, has been awarded the prestigious i-Lab prize for its innovative project aimed at treating inflammatory diseases.
Temper Bio, co-founded and funded by Argobio Studio, is developing…
